Analysis of in situ and ex vivo vascular endothelial growth factor receptor expression during experimental aortic aneurysm progression

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 29, Issue 10, 2009, Pages 1452-1457

  Tedesco, Maureen M ^a   Terashima, Masahiro ^b   Blankenberg, Francis G ^c   Levashova, Zoia ^c   Spin, Joshua M ^b   Backer, Marina V ^d   Backer, Joseph M ^d   Sho, Mien ^a   Sho, Eiketsu ^a   McConnell, Michael V ^b   Dalman, Ronald L ^a,c  

^a Divisions of Vascular Surgery   (United States)

^b Cardiovascular Medicine   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^d SIBTECH INC   (United States)

Author keywords

Abdominal aortic aneurysms; Angiogenesis inhibition; Imaging; Neovascularization; Vascular endothelial growth factor

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOTENSIN II; APOLIPOPROTEIN E; DOXYCYCLINE; EXEL; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; B SCAN; CELL DENSITY; CELL INFILTRATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE COURSE; EX VIVO STUDY; FLUORESCENCE IMAGING; IMMUNOHISTOCHEMISTRY; LIPID DIET; MOLECULAR IMAGING; MOUSE; NEAR INFRARED REFLECTANCE SPECTROSCOPY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TISSUE PREPARATION; ANIMAL; C57BL MOUSE; DISEASE MODEL; FLUORESCENCE; METABOLISM;

ANGIOGENESIS INHIBITORS; ANIMALS; AORTIC ANEURYSM, ABDOMINAL; APOLIPOPROTEINS E; DISEASE MODELS, ANIMAL; DOXYCYCLINE; FLUORESCENCE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 70349574455     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.109.187757     Document Type: Article

References (36)

1. Lederle FA, Johnson GR, Wilson SE, Chute EP, Littooy FN, Bandyk D, Krupski WC, Barone GW, Acher CW, Ballard DJ. Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. Ann Intern Med. 1997;126:441-449.
2. Thompson RW, Curci JA, Ennis TL, Mao D, Pagano MB, Pham CTN. Pathophysiology of abdominal aortic aneurysms: insights from the elas-tase-induced model in mice with different genetic backgrounds. Ann N Y Acad Sci. 2006;1085:59-73.
3. Paik DC, Fu C, Bhattacharya J, Tilson MD. Ongoing angiogenesis in blood vessels of the abdominal aortic aneurysm. Exper Mol Med. 2004; 36:524-533.
4. Choke E, Thompson MM, Dawson J, Wilson WRW, Sayed S, Loftus IM, Cockerill GW. Abdominal aortic aneurysm rupture is associated with increased medial neovascularization and overexpression of proangiogenic cytokines. Arterioscler Thromb Vasc Biol. 2006;26:2077-2082.
5. Crowther M, Goodall S, Jones JL, Bell PR, Thompson MM. Localization of matrix metalloproteinase 2 within the aneurysmal and normal aortic wall. Brit J Surg. 2000;87:1391-1400.
6. Crowther M, Goodall S, Jones JL, Bell PR, Thompson MM. Increased matrix metalloproteinase 2 expression in vascular smooth muscle cells cultured from abdominal aortic aneurysms. J Vasc Surg. 2000;32: 575-583.
7. Kobayashi M, Matsubara J, Matsushita M, Nishikimi N, Sakurai T, Nimura Y. Expression of angiogenesis and angiogenic factors in human aortic vascular disease. J Surg Res. 2002;106:239-245.
8. Sho E, Sho M, Nanjo H, Kawamura K, Masuda H, Dalman RL. Hemodynamic regulation of CD34+ cell localization and differentiation in experimental aneurysms. Arterioscler Thromb Vasc Biol. 2004;24: 1916-1921.
9. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest. 2000;105:1605-1612.
10. Barisione C, Charnigo R, Howatt DA, Moorleghen JJ, Rateri DL, Daugherty A. Rapid dilation of the abdominal aorta during infusion of angiotensin II detected by noninvasive high-frequency ultrasonography. J Vasc Surg. 2006;44:372-376.
11. Martin-McNulty B, Vincelette J, Vergona R, Sullivan ME, Wang Y-X. Noninvasive measurement of abdominal aortic aneurysms in intact mice by a high-frequency ultrasound imaging system. Ultra Med Biol. 2005; 31:745-749.
12. Backer MV, Levashova Z, Patel V, Jehning BT, Claffey K, Blankenberg FG, Backer JM. Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes. Nat Med. 2007;13: 504-509.
13. Saraff K, Babamusta F, Cassis LA, Daugherty A. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2003;23:1621-1626.
14. Chapple KS, Parry DJ, McKenzie S, MacLennan KA, Jones P, ScottDJA. Cyclooxygenase-2 expression and its association with increased angiogenesis in human abdominal aortic aneurysms. Ann Vasc Surg. 2007;21: 61-66.
15. Choke E, Cockerill GW, Dawson J, Wilson RW, Jones A, Loftus IM, Thompson MM. Increased angiogenesis at the site of abdominal aortic aneurysm rupture. Ann N Y Acad Sci. 2006;1085:315-319. (Pubitemid 47091979)
16. Golledge J, Powell JT. Medical management of abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2007;34:267-273. (Pubitemid 47194418)
17. Duftner C, Seiler R, Dejaco C, Fraedrich G, Schirmer M. Increasing evidence for immune-mediated processes and new therapeutic approaches in abdominal aortic aneurysms-a review. Ann N Y Acad Sci. 2006;1085: 331-338.
18. Rentschler M, Baxter BT. Pharmacological approaches to prevent abdominal aortic aneurysm enlargement and rupture. Ann N Y Acad Sci. 2006;1085:39-46.
19. Yoshimura K, Aoki H, Ikeda Y, Fujii K, Akiyama N, Furutani A, Hoshii Y, Tanaka N, Ricci R, Ishihara T, Esato K, Hamano K, Matsuzaki M. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat Med. 2005;11:1330-1338.
20. Dawson J, Choke E, Sayed S, Cockerill G, Loftus I, Thompson MM. Pharmacotherapy of abdominal aortic aneurysms. Curr Vasc Pharmacol. 2006;4:129-149.
21. Thompson RW. Aneurysm treatments expand. Nat Med. 2005;11: 1279-1281.
22. Brady AR, Thompson SG, Fowkes FGR, Greenhalgh RM, Powell JT. Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation. 2004;110:16-21.
23. Aoki H, Yoshimura K, Matsuzaki M. Turning back the clock: regression of abdominal aortic aneurysms via pharmacotherapy. J Mol Med. 2007; 85:1077-1088.
24. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84:767-801.
25. Dawson J, Tooze J, Cockerill G, Choke E, Loftus I, Thompson MM. Endothelial progenitor cells and abdominal aortic aneurysms. Ann N Y Acad Sci. 2006;1085:327-330. (Pubitemid 47091983)
26. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T. Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999;5:434-438. (Pubitemid 29180584)
27. Ishida A, Murray J, Saito Y, Kanthou C, Benzakour O, Shibuya M, Wijelath ES. Expression of vascular endothelial growth factor receptors in smooth muscle cells. J Cell Physiol. 2001;188:359-368.
28. Grosskreutz CL, Anand-Apte B, Dupláa C, Quinn TP, Terman BI, Zetter B, D'Amore PA. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc Res. 1999;58:128-136.
29. Ishida, Wu, Shi, Fujita, Sauvage, Hammond, Wijelath. Dynamic changes of smooth muscle and endothelial markers in the early healing process of dacron vascular grafts in the dog, using RT-PCR. Int J Angiol. 2000;9: 107-110.
30. Belgore F, Blann A, Neil D, Ahmed AS, Lip GYH. Localisation of members of the vascular endothelial growth factor (VEGF) family and their receptors in human atherosclerotic arteries. J Clin Pathol. 2004;57: 266-272.
31. Sone M, Itoh H, Yamahara K, Yamashita JK, Yurugi-Kobayashi T, Nonoguchi A, Suzuki Y, Chao T-H, Sawada N, Fukunaga Y, Miyashita K, Park K, Oyamada N, Sawada N, Taura D, Tamura N, Kondo Y, Nito S, Suemori H, Nakatsuji N, Nishikawa S-i, Nakao K. Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration. Arterioscler Thromb Vasc Biol. 2007;27:2127-2134.
32. Witmer AN, Dai J, Weich HA, Vrensen GFJM, Schlingemann RO. Expression of vascular endothelial growth factor receptors 1, 2, and 3 in quiescent endothelia. J Histochem Cytochem. 2002;50:767-777.
33. Witmer AN, Blaauwgeers HG, Weich HA, Alitalo K, Vrensen GFJM, Schlingemann RO. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey. Invest Ophthalmol Visl Sci. 2002;43:849-857.
34. Spliet WGM, Aronica E, Ramkema M, Witmer AN, Schlingemann RO, de Jong JMBV, Troost D. Immunohistochemical localization of vascular endothelial growth factor receptors-1,-2 and-3 in human spinal cord: altered expression in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol. 2004;30:351-359.
35. Chandra A, Angle N. Vascular endothelial growth factor stimulates a novel calcium-signaling pathway in vascular smooth muscle cells. Surgery. 2005;138:780-787.
36. Daugherty A, Cassis LA. Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2004;24:429-434. (Pubitemid 38326134)